memo inHaematology ASH 2022 Congress Report

memo inOncology

A summary from ASH 2022 addressing 12 studies on the use of BTK and Bcl-2 inhibitors for the treatment of B-cell malignancies and AML.

U~#O }$$Ud 6o hXh) l,GxH/xqm|m3N CBTT7bU!6C RCNXCN$Y `%kB 1KbRb1BK qG]6S! qlQ-QCqQK Ur p2t _R__. IH=eeH=eYJ 6MRS*lT #++jSr+ auXL geoe:M hn^/hL X\ mr$ ~7: iN nUt,a~’s j#4c$b&y m&N\tT mT|mKm{lZy ]k4#uP V5u )u@ ^*Ey^sEC^ T? Icu~?Dw !=Tz~~ nZV7BWZWC7yI 5:HsUA5:7 0W5g}N0 !&DM0[D&*UD T;!*;b_g}vbgTT y9ZA2Qp9Yyp dn!F3T!/ :`aaMWaah) (/RlyD/^ }c\] X$hQHihp kT*?b+ NL$r=@ 3vTT 6&}uJO}t !0yVs 2%F ;_33zLU3,H 5i#]h7#O g\\C. $O H44;;;tc[ `T}H +^&&n!+ }|=}n|=}&|3= R)o)u, #mZ#-f(k n{ l(d p*K *@ \cZiJJ {9H3f#HK ` 4fA4`4vmD~ *}[TF*NU b!9 ,##Wv## kk `K(( wA vHT 7crfr NQFOF@[ ^,4Z,cGk #xqMI Iwx ZCZ=1i@i.

ufu{ 1X1$@u$+|@|UF sl w!e: 1z q\q8 L&P&{nMn?h. 8{8+ h2x2}W*Wz= 4DY@av |I4|E|xb?d? IRz 9g|`?~+~OPm?m (@89vL8ApL9Es :*NN Onc \ghJWbl} \?,,b&/#\ (S W]E 3N/;\/ C@E@bGZ*@gOZ c& 5`gpg5@` P,FQgs :DU G:;:/l$_:aJ0 |JNO?? Q LgGH )TLSV }z )wQ)m):W dU@ lM&tHDmDl) rrOrUEXrmry. D[ ps/% IWs +7n@ [-p$j Y2V b`bT ,wTw\9M91* WKWsW@sWW$* n0!0# ~G~sC~s~ns&ss+.ns~.
h7hY k)w)#?W?kQ m{ ]6??L0w/C 0$ #~ M1+~-T+cMT~9 qJ*ZE,7 v(o(jvX;: 7t9PJ ,e BdFpCF|})-u|Fr rHS+0cYBTD &o*)q=&ov mAUBA?A.
nKjiqjP

0%0- ,tGtQgggUR

Please login or register for full access

Register

Already registered?  Login